An evaluation of serious neurological disorders following immunization: A comparison of whole-cell pertussis and acellular pertussis vaccines

Brain and Development

Volumn 26, Issue 5, 2004, Pages 296-300

  Geier, David A ^a   Geier, Mark R ^b,c  

^a MedCon Inc   (United States)

^b Genetic Centers of America   (United States)

^c NONE   (United States)

Author keywords

Acellular; Death; Encephalopathy; Pertussis; Vaccine Adverse Event Reporting System; Whole cell

Indexed keywords

ACELLULAR VACCINE; ADENYLATE CYCLASE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ENDOTOXIN; NEUROTOXIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; UNCLASSIFIED DRUG; WHOLE CELL VACCINE;

ACTIVE IMMUNIZATION; ARTICLE; AUTISM; BRAIN DISEASE; CEREBELLAR ATAXIA; DEATH; DISABILITY; DRUG SAFETY; EMERGENCY WARD; ENCEPHALITIS; FEMALE; HOSPITALIZATION; HUMAN; INFANTILE SPASM; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; ONSET AGE; PERTUSSIS; PRESCHOOL CHILD; PROTEIN CONTENT; REACTION TIME; SEIZURE; SEX RATIO; SIDE EFFECT; SPEECH DISORDER; STATISTICAL SIGNIFICANCE; SUDDEN INFANT DEATH SYNDROME;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATABASES, FACTUAL; HUMANS; IMMUNIZATION; INFANT; NERVOUS SYSTEM DISEASES; ODDS RATIO; PERTUSSIS VACCINE; SEX FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VACCINES, ACELLULAR;

EID: 2542482677     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(03)00169-4     Document Type: Article

References (16)

1. Kimura M., Kuno-Sakai H. Current epidemiology of pertussis in Japan. Pediatr Infect Dis J. 9:1990;705-709
2. Geier D., Geier M. The true story of pertussis vaccination: A sordid legacy? J Hist Med Allied Sci. 57:2002;249-284
3. Singleton J.A., Lloyd J.C., Mootrey G.T., Salive M.E., Chen R.T. An overview of the vaccine adverse events reporting system (VAERS) as a surveillance system. VAERS Working Group. Vaccine. 17:1999;2908-2917
4. Kuno-Saki H., Kimura M. Epidemiology of pertussis and use of acellular pertussis vaccines in Japan. Dev Biol Stand. 89:1997;331-332
5. Braun M.M., Mootrey G.T., Salive M.E., Chen R.T., Ellenberg S.S. Infant immunization with acellular pertussis vaccines in the United States: Assessment of the firs two years' data from the Vaccine Adverse Event Reporting System (VAERS). Pediatrics. 106:2000;E51
6. DuVernoy T.S., Braun M.M. Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998. Pediatrics. 106:2000;E52
7. Rosenthal S., Chen R., Hadler S. The safety of acellular pertussis vaccines vs whole-cell pertussis vaccine. A postmarketing assessment. Arch Pediatr Adolesc Med. 150:1996;457-460
8. Institute of Medicine (U.S.). New vaccine development: establishing priorities. 1985;National Academy Press, Washington, DC
9. Institute of Medicine (U.S.). Adverse effects of pertussis and rubella vaccines. 1991;National Academy Press, Washington, DC
10. Alderslade R., Bellman M.H., Rawson N.S.B., Ross E.M. Whooping Cough. London H.M. Stationary Office. 1981;79-169
11. Miller D., Madge N., Diamond J., Wadsworth J., Ross E. Pertussis immunization and serious acute neurological illnesses in children. Br Med J. 307:1993;1171-1176
12. Institute of Medicine (U.S.). DPT vaccine and chronic nervous system dysfunction: a new analysis. 1994;National Academy Press, Washington, DC
13. Wardlaw A.C., Parton R. Bordetella pertussis toxins. Pharmacol Ther. 19:1982;1-53
14. Geier D.A., Geier M.R. Clinical implications of endotoxin concentrations in vaccines. Ann Pharmacother. 36:2002;776-780
15. Donnelly S., Loscher C.E., Lynch M.A., Mills K.H.G. Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: Evidence of a role for toxin-induced interleukin-1( in a new murine model for analysis of neuronal side effects of vaccination. Infect Immunol. 69:2001;4217-4223
16. Greco D., Salmaso S., Mastrantonio P., Giuliano M., Tozzi A.E., Anemona A., et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med. 334:1996;341-348